Valuation: ALTEOGEN Inc.

Market Cap 16,95300Cr 1.14TCr 995.69Cr 922.19Cr 848.52Cr 1.6TCr 1,08700Cr 1.64TCr 11TCr 4.31TCr 53TCr 4.26TCr 4.17TCr 1,84300Cr P/E 2026 *
57.9x
P/E 2027 * 38.8x
Enterprise Value 1.65TCr 1.1Cr 96.64L 89.51L 82.36L 1.56Cr 105.46Cr 1.59Cr 11Cr 4.18Cr 52Cr 4.14Cr 4.05Cr 178.85Cr EV / Sales 2026 *
35.1x
EV / Sales 2027 * 24x
Free-Float
74.26%
Yield 2026 *
0.16%
Yield 2027 * 0.17%
1 day-2.31%
1 week-4.38%
Current month-12.33%
1 month-6.08%
3 months-10.47%
6 months-33.72%
Current year-29.59%
1 week 2,98,500
Extreme 298500
3,44,000
1 month 2,98,500
Extreme 298500
3,97,500
Current year 2,86,000
Extreme 286000
5,29,000
1 year 2,86,000
Extreme 286000
5,69,000
3 years 40,150
Extreme 40150
5,69,000
5 years 27,875
Extreme 27875
5,69,000
10 years 3,645.83
Extreme 3645.8333
5,69,000
Manager TitleAgeSince
Chief Executive Officer 60 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap.
21/25/21Fiscal year

Chief Executive Officer

7,200 0.0135%
27/24/27Sell 16,00,000 3.0182%
05/24/05Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-2.31%-4.38%-27.90%+660.82% 1.14TCr
-0.22%+2.04%+16.79%-8.03% 6.75TCr
-0.81%-8.00%+35.32%+194.38% 5.11TCr
+0.36%+40.00%+40.00%+40.00% 4.34TCr
+1.34%-0.81%-49.11%-52.89% 4.03TCr
+4.96%+0.27%+55.75%-24.80% 3.09TCr
-1.85%-18.08%+99.20%-47.07% 2.66TCr
-2.12%-1.20%+66.54%+84.42% 2.28TCr
+1.07%+3.27%+9.82%+177.50% 1.98TCr
-0.89%-4.50%+55.11%+125.27% 1.65TCr
Average +0.40%-3.89%+30.15%+114.96% 3.3TCr
Weighted average by Cap. +0.51%-3.16%+28.34%+66.59%

Financials

2026 *2027 *
Net sales 47TCr 31Cr 28Cr 25Cr 23Cr 44Cr 3TCr 45Cr 303.91Cr 119.2Cr 1.48TCr 117.87Cr 115.29Cr 5.1TCr 67TCr 45Cr 39Cr 37Cr 34Cr 64Cr 4.31TCr 65Cr 435.79Cr 170.92Cr 2.12TCr 169.01Cr 165.32Cr 7.31TCr
Net income 31TCr 21Cr 18Cr 17Cr 16Cr 29Cr 1.99TCr 30Cr 201.42Cr 79Cr 977.82Cr 78Cr 76Cr 3.38TCr 40TCr 27Cr 23Cr 22Cr 20Cr 38Cr 2.54TCr 38Cr 257.12Cr 100.84Cr 1.25TCr 100Cr 98Cr 4.31TCr
Net Debt -50TCr -33Cr -29Cr -27Cr -25Cr -47Cr -3.2TCr -48Cr -323.41Cr -126.84Cr -1.57TCr -125.43Cr -122.69Cr -5.42TCr -83TCr -55Cr -49Cr -45Cr -41Cr -78Cr -5.3TCr -80Cr -536.61Cr -210.46Cr -2.6TCr -208.12Cr -203.57Cr -9TCr
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
13/26/13 ₩3,16,500.00 -2.31% 4,27,149
10/26/10 ₩3,24,000.00 +8.00% 5,31,416
09/26/09 ₩3,00,000.00 -4.31% 4,83,783
08/26/08 ₩3,13,500.00 -7.11% 4,52,829
07/26/07 ₩3,37,500.00 +1.96% 3,55,590
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
3,16,500.00KRW
Average target price
4,58,000.00KRW
Spread / Average Target
+44.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock